|
Volumn 165, Issue 5, 2014, Pages 584-584
|
Resolution of methotrexate-induced Epstein-Barr virus-associated mucocutaneous ulcer
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CD15 ANTIGEN;
CD20 ANTIGEN;
INTERFERON REGULATORY FACTOR 4;
LATENT MEMBRANE PROTEIN 1;
METHOTREXATE;
ORGANIC CATION TRANSPORTER 2;
PROTEIN BCL 6;
IMMUNOSUPPRESSIVE AGENT;
AGED;
ARTICLE;
B LYMPHOCYTE;
BIOPSY TECHNIQUE;
CASE REPORT;
COMPUTER ASSISTED TOMOGRAPHY;
DRUG WITHDRAWAL;
EPSTEIN BARR VIRUS;
EPSTEIN BARR VIRUS INFECTION;
FLOW CYTOMETRY;
HARD PALATE;
HUMAN;
IMMUNE DEFICIENCY;
LYMPHOCYTIC INFILTRATION;
LYMPHOID CELL;
LYMPHOMA;
MALE;
MONOCLONAL IMMUNOGLOBULINEMIA;
MOUTH LESION;
MOUTH ULCER;
MUCOCUTANEOUS INFECTION;
MUCOCUTANEOUS ULCER;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PARESIS;
PRIORITY JOURNAL;
REED STERNBERG CELL;
RHEUMATOID ARTHRITIS;
T LYMPHOCYTE;
COMPLICATION;
IMMUNOCOMPROMISED PATIENT;
IMMUNOLOGY;
LYMPHOPROLIFERATIVE DISEASE;
PATHOLOGY;
VIROLOGY;
AGED;
EPSTEIN-BARR VIRUS INFECTIONS;
HUMANS;
IMMUNOCOMPROMISED HOST;
IMMUNOSUPPRESSIVE AGENTS;
LYMPHOPROLIFERATIVE DISORDERS;
MALE;
METHOTREXATE;
ORAL ULCER;
|
EID: 84900477257
PISSN: 00071048
EISSN: 13652141
Source Type: Journal
DOI: 10.1111/bjh.12743 Document Type: Article |
Times cited : (21)
|
References (0)
|